Milestone Scientific - Advanced Injection Technology

CompuMed ^® Instrument

» Product Description
» Our Distributors

CompuFlo^® System
Applications in Research
and Development

» Epidurals

» Intra-Articular Injections

» Self Injections

» Neurosurgical

» Ophthalmic Surgery

» Dermal Filler/Cosmetic

In 2004, clinical studies involving Epidural Analgesia using our CompuFlo^® system technology were conducted at the University of Texas Health Science Center at Houston under the guidance of Dr. Oscar Ghelber, Assistant Professor Anesthesiology.

Results of the initial study revealed that the CompuFlo system detects pressure changes as the needle penetrates human tissue with differing characteristics. Researchers confirmed that the CompuFlo system:

Clearly and successfully identified the epidural space in 100% of the test subjects.
Clearly identified false readings.
Provides precise and objective feedback.
Allows anesthesiologists to use both hands to advance and direct the needle.

The study concluded that objective identification of the epidural space could potentially decrease the incidence of complications, increase the success rate of the procedure and enhance patient safety.

In a follow-on study completed in early 2005, Dr. Ghelber’s team reconfirmed that the CompuFlo system reliably identified, in all cases, the pressure characteristics of different tissues, including the pressure that characterizes the epidural space. Moreover, it was determined that the location of the needle can be easily determined within seconds.

The application benefits of Milestone’s CompuFlo-based Epidural Injection System are numerous and well defined, and include:

materially reducing, and possibly eliminating, existing medical risks and complications associated with administering epidurals;
improving patient safety and comfort;
reducing liability to medical care providers/institutions; and
reducing malpractice clams and related insurance premiums for anesthesiologists.